Intracranial Stenosis Stents Market Analysis

Intracranial Stenosis Stents Market Analysis

The intracranial stenosis stents market by type is categorized into self-expanding stents, embolization coil support intracranial stents, venous sinus stents, and balloon-expanding stents. The self-expanding stents segment garnered USD 286.3 million revenue size in the year 2022. Self-expanding stents offer several advantages including minimally invasive deployment, accurate placement, flexibility, reduced risk of complications, and long-term stability. The less invasive procedure with smaller incisions leads to faster recovery times and shorter hospital stays, making self-expanding stents a preferred choice for patients and healthcare providers. With lower risks of adverse events and long-term stability, self-expanding stents are increasingly adopted in neuro interventional procedures contributing to the overall market growth.
 

Based on end-use, the intracranial stenosis stents market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market and accounted for 80.5% business share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Hospitals have specialized neurovascular centers with skilled healthcare professionals and advanced medical equipment, allowing for accurate diagnosis and treatment of intracranial stenosis. Their multidisciplinary approach and higher patient volume contribute to the frequent utilization of intracranial stenosis stents.
 

Moreover, hospitals' established relationships with insurance companies and participation in research and clinical trials further promotes the adoption of cutting-edge stent technologies. The availability of reimbursement and insurance coverage also facilitates patient access to these devices. Thus, hospitals' expertise, resources, and capacity to treat a large number of patients with complex neurological conditions significantly influence the demand for intracranial stenosis stents, thereby driving the market progress.
 

U.S. intracranial stenosis stents market accounted for USD 281.1 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The U.S. has a high prevalence of neurological conditions, including intracranial stenosis due to factors such as an aging population and an increasing incidence of risk factors such as hypertension, diabetes, and high cholesterol. For instance, according to the Centers for Disease Control and Prevention (CDC) in the U.S. over 795,000 people experience a stroke annually with approximately 610,000 being first-time occurrences, and ischemic strokes, obstructing blood flow to the brain, constitute 87% of all strokes.
 

Moreover, the American Stroke Association's report indicates there is a rising trend in stroke cases among younger and middle-aged adults (below 49), particularly in the South and Midwest regions of the country. This higher disease burden drives the demand for intracranial stenosis stents as an effective treatment option. Furthermore, the U.S. serves as a hub for medical research and development, leading to continuous innovation and the introduction of advanced stent technologies. Growing awareness about neurological conditions and the concentration of leading medical device companies in the country will further bolster the market expansion.